The 2026/27 QOF will see GPs receive £3,000 to maximise Mounjaro prescribing, aiming to widen NHS access and reduce inequalities in GLP-1 weight loss treatment, while raising key considerations for aesthetic professionals around regulation, patient safety and holistic weight management.
Read More